Proposed changes to the recommended use of meningococcal B vaccines in people at increased risk of meningococcal B disease

Overview

The Australian Technical Advisory Group on Immunisation (ATAGI) is consulting with stakeholders on proposed changes to recommended use of meningococcal B vaccines in people at increased risk of meningococcal B disease for inclusion in the Australian Immunisation Handbook, with an intention to submit the recommendation to the National Health and Medical Research Council (NHMRC) for its approval under section 14A of the National Health and Medical Research Council Act 1992.

The draft recommendations and the rationale for the changes are outlined in the attached public consultation document (see below).

Submission instructions

This public consultation will be open for a period of 31 days and you are invited to make a submission on the draft recommendation by 11.59PM on Sunday 17 July 2022.

If you have any questions in relation to this consultation process please contact the ATAGI Secretariat via email at atagi.secretariat@health.gov.au.

Your contribution is greatly appreciated.

How do I make a submission?

To make a submission, please click on the ‘Online Survey’ link below and follow the instructions. Please ensure you provide the page and section to which each of your comments refer. The ATAGI will not accept:

• Comments received after the consultation deadline (11.59PM on 17 July 2022);
• Confidential information that you do not wish to make public; or
• Comments which, in the opinion of the ATAGI, are incorrect or inappropriate.